Antisense oligonucleotides for the treatment of Leber congenital amaurosis

摘要

The present invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Leber congenital amaurosis.